Oneto, Caterina
Vanguard Gastroenterology, New York, New York
2 papers on CoChatORCID 0009-0006-4553-2221
Most cited papers
- Verified
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Sims, M. D., Khanna, S., Feuerstadt, P., Louie, T. J., Kelly, C. R., Huang, E. S., Hohmann, E. L., Wang, E. E. L., Oneto, C., Cohen, S. H., et al. (2023) · JAMA Network Open
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 83
- Verified
742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Downs, I. A., Zanetti-Yabur, A., Ramos, Y., Cotto, C. L., et al. (2018) · Gastroenterology
Gastrointestinal motility and disordersInflammatory Bowel Disease
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free